provigil - An Overview
Experiences of serious dermatologic adverse consequences and psychiatric events has resulted during the FDA's Pediatric Advisory Committee unanimously recommending that a specific warning in opposition to the use of modafinil in young children be added on the manufacturer's labeling; use provided that initially- and second-line therapies have unsuc